Gilead to charge governments $2,340 for Covid-19 treatment remdesivir
Published
US drugmaker releases proposed pricing for one of most promising coronavirus medicines
Full ArticlePublished
US drugmaker releases proposed pricing for one of most promising coronavirus medicines
Full ArticleGilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022,..